RMPEC: Red de medicina de precisión en enfermedades complejas
Vall d'Hebron Institut de Recerca
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (8)
2024
-
Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities
Pediatric Blood and Cancer, Vol. 71, Núm. 8
2021
-
Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes
Molecular Therapy - Methods and Clinical Development, Vol. 22, pp. 66-75
-
PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion
Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218
2019
-
Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia
Nature Medicine, Vol. 25, Núm. 9, pp. 1396-1401
2014
-
Pharmacogenetics of MicroRNAs and MicroRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia
PLoS ONE, Vol. 9, Núm. 3
-
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations
Molecular Cancer, Vol. 13, Núm. 1
2013
-
Intron 3 of the ARID5B gene: A hot spot for acute lymphoblastic leukemia susceptibility
Journal of Cancer Research and Clinical Oncology, Vol. 139, Núm. 11, pp. 1879-1886
-
Polymorphisms in the methotrexate transport pathway: A new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia
Pharmacogenetics and Genomics, Vol. 23, Núm. 2, pp. 53-61